Found: 131
Select item for more details and to access through your institution.
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 5/6, p. 344, doi. 10.3109/21678421.2014.884592
- By:
- Publication type:
- Article
Cognitive performance following spontaneous subarachnoid haemorrhage versus other forms of intracranial haemorrhage.
- Published in:
- British Journal of Neurosurgery, 2014, v. 28, n. 1, p. 68, doi. 10.3109/02688697.2013.815314
- By:
- Publication type:
- Article
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2025, v. 272, n. 1, p. 1, doi. 10.1007/s00415-024-12763-w
- By:
- Publication type:
- Article
Cerebrospinal fluid–related tissue damage in multiple sclerosis patients with iron rim lesions.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 4/5, p. 549, doi. 10.1177/13524585231155639
- By:
- Publication type:
- Article
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 182, doi. 10.1177/13524585221134217
- By:
- Publication type:
- Article
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 169, doi. 10.1177/13524585221134213
- By:
- Publication type:
- Article
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome – Where do we stand?
- Published in:
- Journal of Neurology, 2009, v. 256, n. 1, p. 3, doi. 10.1007/s00415-009-0097-x
- By:
- Publication type:
- Article
Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.
- Published in:
- Journal of Neurology, 2007, v. 254, p. II69, doi. 10.1007/s00415-007-2016-3
- By:
- Publication type:
- Article
Rare indications of IVIG therapy in neurological diseases based on case reports and small studies.
- Published in:
- Journal of Neurology, 2006, v. 253, p. v66, doi. 10.1007/s00415-006-5011-1
- By:
- Publication type:
- Article
Isolated blood–cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.
- Published in:
- Journal of Neurology, 2005, v. 252, n. 9, p. 1067, doi. 10.1007/s00415-005-0817-9
- By:
- Publication type:
- Article
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.
- Published in:
- Journal of Neurology, 2004, v. 251, n. 12, p. 1498, doi. 10.1007/s00415-004-0580-3
- By:
- Publication type:
- Article
Interferon-ß-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2003, v. 250, n. 10, p. 1224, doi. 10.1007/s00415-003-0191-4
- By:
- Publication type:
- Article
The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 977, doi. 10.3390/jpm12060977
- By:
- Publication type:
- Article
Cerebrospinal fluid markers of idiopathic intracranial hypertension: Is the renin-angiotensinogen system involved?
- Published in:
- Cephalalgia, 2011, v. 31, n. 1, p. 116, doi. 10.1177/0333102410375726
- By:
- Publication type:
- Article
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
- Published in:
- Proteomics, 2010, v. 10, n. 1, p. 81, doi. 10.1002/pmic.200900246
- By:
- Publication type:
- Article
Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89514-8
- By:
- Publication type:
- Article
Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes.
- Published in:
- Neuropathology & Applied Neurobiology, 2019, v. 45, n. 3, p. 318, doi. 10.1111/nan.12491
- By:
- Publication type:
- Article
Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.
- Published in:
- BMC Neurology, 2016, v. 16, p. 1, doi. 10.1186/s12883-016-0707-z
- By:
- Publication type:
- Article
Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitis.
- Published in:
- Acta Neuropathologica, 1997, v. 93, n. 3, p. 215, doi. 10.1007/s004010050606
- By:
- Publication type:
- Article
Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2874, doi. 10.3390/jcm9092874
- By:
- Publication type:
- Article
Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2025, doi. 10.3390/jcm9072025
- By:
- Publication type:
- Article
Laborchemische Diagnostik der Liquorrhoe.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2007, v. 31, n. 5, p. 201, doi. 10.1515/JLM.2007.038
- By:
- Publication type:
- Article
ERK2 is Increased in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 1, p. 119, doi. 10.3233/JAD-2010-100030
- By:
- Publication type:
- Article
Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 17, n. 3, p. 541, doi. 10.3233/JAD-2009-1075
- By:
- Publication type:
- Article
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 8, p. 1591, doi. 10.1515/cclm-2023-1256
- By:
- Publication type:
- Article
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0088680
- By:
- Publication type:
- Article
Communicating Hydrocephalus Following Eosinophilic Meningitis Is Pathogenic for Chronic Viliuisk Encephalomyelitis in Northeastern Siberia.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0084670
- By:
- Publication type:
- Article
Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068996
- By:
- Publication type:
- Article
Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson's Disease Dementia.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048783
- By:
- Publication type:
- Article
Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023600
- By:
- Publication type:
- Article
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS).
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0011986
- By:
- Publication type:
- Article
A Proteomic Approach for the Diagnosis of Bacterial Meningitis.
- Published in:
- PLoS ONE, 2010, v. 5, n. 4, p. 1, doi. 10.1371/journal.pone.0010079
- By:
- Publication type:
- Article
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage.
- Published in:
- PLoS ONE, 2009, v. 4, n. 10, p. 1, doi. 10.1371/journal.pone.0007624
- By:
- Publication type:
- Article
A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00608
- By:
- Publication type:
- Article
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.
- Published in:
- Frontiers in Neurology, 2019, v. 10, p. 1, doi. 10.3389/fneur.2019.01179
- By:
- Publication type:
- Article
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
- Published in:
- Proteomics - Clinical Applications, 2010, v. 4, n. 8/9, p. 745, doi. 10.1002/prca.201090025
- By:
- Publication type:
- Article
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1204, doi. 10.1002/alz.12751
- By:
- Publication type:
- Article
Markers of vitamin B12 status in relation to CSF biomarkers and cognitive performance.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.059799
- By:
- Publication type:
- Article
The potential role of neuroinflammation and synaptic plasticity for neuropsychiatric symptoms: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.043310
- By:
- Publication type:
- Article
The potential role of neuroinflammation and synaptic plasticity for neuropsychiatric symptoms: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043310
- By:
- Publication type:
- Article
Chitinase Enzyme Activity in Cerebral Spinal Fluid is Strongly Associated with Alzheimer’s Disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Glial fibrillary acidic protein and protein S-100B: Different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer' s disease and Creutzfeldt-Jakob disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Genetic variants in presenilins and correlation to amyloid-beta 42 levels in cerebrospinal fluid and diagnosis of Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Abeta 42-1 correlates with learning potential as measured by a plasticity-based test approach
- Published in:
- 2009
- By:
- Publication type:
- Abstract
TDP-43 and beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration
- Published in:
- 2009
- By:
- Publication type:
- Abstract
S4-01-05: Peptidomics analysis of cerebrospinal fluid for the detection of possible biomarkers for Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
S4-01-05: Peptidomics analysis of cerebrospinal fluid for the detection of possible biomarkers for Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract